Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001415889-19-001569

CHAIRMAN AND CEO gave up 15,806 shares (to pay taxes)

  • CHAIRMAN AND CEO acquired 35,599 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ward Robert CHAIRMAN AND CEO 2019-12-26 Option exercise +35,599 206,552 D
Ward Robert CHAIRMAN AND CEO 2019-12-26 Shares withheld for taxes −15,806 $7.26 $114,752 190,746 D
Derivatives
Ward Robert CHAIRMAN AND CEO 2019-12-26 Option exercise · Restricted Stock Units −35,599 284,794 D
Loading xslF345X03/form4-12272019_041201.xml…